메뉴 건너뛰기




Volumn 48, Issue 4-5, 2013, Pages 775-780

Drug "supersaturation" states induced by polymeric micelles and liposomes: A mechanistic investigation into permeability enhancements

Author keywords

Apparent solubility; Lipophilic drug; Permeability enhancement; Polymeric micelles; True supersaturation

Indexed keywords

D ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE; HYDROCORTISONE; PHOSPHATIDYLCHOLINE; POVIDONE; SOLUBILIZER; UNCLASSIFIED DRUG;

EID: 84873709478     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.01.006     Document Type: Article
Times cited : (39)

References (24)
  • 1
    • 0022359497 scopus 로고
    • Improving the intestinal mucosal cell uptake of water insoluble compounds
    • G.L. Amidon Improving the intestinal mucosal cell uptake of water insoluble compounds J. Controlled Release 2 1985 13 26
    • (1985) J. Controlled Release , vol.2 , pp. 13-26
    • Amidon, G.L.1
  • 2
    • 33748778747 scopus 로고    scopus 로고
    • Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: Creation of a drug supersaturated state
    • J.M. Barichello, H. Handa, M. Kisyku, T. Shibata, T. Ishida, and H. Kiwada Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state J. Controlled Release 115 2006 94 102
    • (2006) J. Controlled Release , vol.115 , pp. 94-102
    • Barichello, J.M.1    Handa, H.2    Kisyku, M.3    Shibata, T.4    Ishida, T.5    Kiwada, H.6
  • 3
    • 68249128120 scopus 로고    scopus 로고
    • Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?
    • J. Brouwers, M.E. Brewster, and P. Augustijns Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J. Pharm. Sci. 98 2009 2549 2572
    • (2009) J. Pharm. Sci. , vol.98 , pp. 2549-2572
    • Brouwers, J.1    Brewster, M.E.2    Augustijns, P.3
  • 4
    • 41349119990 scopus 로고    scopus 로고
    • Combination of pluronic/vitamin e TPGS as a potential inhibitor of drug precipitation
    • W. Dai, L.C. Dong, S. Li, and Z. Deng Combination of pluronic/vitamin E TPGS as a potential inhibitor of drug precipitation Int. J. Pharm. 355 2008 31 37
    • (2008) Int. J. Pharm. , vol.355 , pp. 31-37
    • Dai, W.1    Dong, L.C.2    Li, S.3    Deng, Z.4
  • 5
    • 79959603915 scopus 로고    scopus 로고
    • Liposomal solubilization of new 3-hydroxy-qionolinone derivatives with promising anticancer activity: A screening method to identify maximum incorporation capacity
    • M. Di Cagno, J. Styskala, J. Hlaváč, M. Brandl, A. Bauer-Brandl, and N. Skalko-Basnet Liposomal solubilization of new 3-hydroxy-qionolinone derivatives with promising anticancer activity: a screening method to identify maximum incorporation capacity J. Lipos. Res. 21 2011 272 278
    • (2011) J. Lipos. Res. , vol.21 , pp. 272-278
    • Di Cagno, M.1    Styskala, J.2    Hlaváč, J.3    Brandl, M.4    Bauer-Brandl, A.5    Skalko-Basnet, N.6
  • 7
    • 2342481809 scopus 로고    scopus 로고
    • Lessons learned from marketed and investigational prodrugs
    • P.G. Ettmayer, G.L. Amidon, B. Clement, and B. Testa Lessons learned from marketed and investigational prodrugs J. Med. Chem. 47 2004 2393 2404
    • (2004) J. Med. Chem. , vol.47 , pp. 2393-2404
    • Ettmayer, P.G.1    Amidon, G.L.2    Clement, B.3    Testa, B.4
  • 8
    • 34547864243 scopus 로고    scopus 로고
    • Drug delivery strategies for poorly water-soluble drugs
    • A. Fahr, and X. Liu Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Deliv. 4 2007 403 416
    • (2007) Expert Opin. Drug Deliv. , vol.4 , pp. 403-416
    • Fahr, A.1    Liu, X.2
  • 9
    • 80054996010 scopus 로고    scopus 로고
    • Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across caco-2 cell monolayers
    • S.M. Fischer, M. Brandl, and G. Fricker Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across caco-2 cell monolayers Eur. J. Pharm. Biopharm. 79 2011 416 422
    • (2011) Eur. J. Pharm. Biopharm. , vol.79 , pp. 416-422
    • Fischer, S.M.1    Brandl, M.2    Fricker, G.3
  • 11
    • 0021257379 scopus 로고
    • Influence of liposomal drug entrapment on percutaneous absorption
    • M.G. Ganesan, N.D. Weiner, G.L. Flynn, and N.F.H. Ho Influence of liposomal drug entrapment on percutaneous absorption Int. J. Pharm. 20 1984 139 154
    • (1984) Int. J. Pharm. , vol.20 , pp. 139-154
    • Ganesan, M.G.1    Weiner, N.D.2    Flynn, G.L.3    Ho, N.F.H.4
  • 12
    • 0029760056 scopus 로고    scopus 로고
    • Nasal delivery. the use of animal models to predict performance in man
    • L. Illium Nasal delivery. The use of animal models to predict performance in man J. Drug Target. 3 1996 427 442
    • (1996) J. Drug Target. , vol.3 , pp. 427-442
    • Illium, L.1
  • 13
    • 33749987516 scopus 로고    scopus 로고
    • Permeability assessment of poorly water-soluble compounds under solubilizing conditions, the reciprocal permeability approach
    • K. Katneni, S.A. Charman, and C.J.H. Porter Permeability assessment of poorly water-soluble compounds under solubilizing conditions, the reciprocal permeability approach J. Pharm. Sci. 95 2006 2170 2185
    • (2006) J. Pharm. Sci. , vol.95 , pp. 2170-2185
    • Katneni, K.1    Charman, S.A.2    Porter, C.J.H.3
  • 14
    • 0342561507 scopus 로고    scopus 로고
    • The effect of water-soluble polymers on aqueous solubility of drugs
    • T. Loftsson, H. Fridriksdóttir, and T.K. Gudmundsdóttir The effect of water-soluble polymers on aqueous solubility of drugs Int. J. Pharm. 127 1996 293 296
    • (1996) Int. J. Pharm. , vol.127 , pp. 293-296
    • Loftsson, T.1    Fridriksdóttir, H.2    Gudmundsdóttir, T.K.3
  • 16
    • 0032927356 scopus 로고    scopus 로고
    • The effect of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs
    • M. Mosharraf, T. Sebhatu, and C. Nyström The effect of disordered structure on the solubility and dissolution rates of some hydrophilic, sparingly soluble drugs Int. J. Pharm. 177 1999 29 51
    • (1999) Int. J. Pharm. , vol.177 , pp. 29-51
    • Mosharraf, M.1    Sebhatu, T.2    Nyström, C.3
  • 17
    • 72449187503 scopus 로고    scopus 로고
    • Prodrug approaches for enhancing the bioavailability of drugs with low solubility
    • C.E. Muller Prodrug approaches for enhancing the bioavailability of drugs with low solubility Chem. Biodivers. 6 2009 2071 2083
    • (2009) Chem. Biodivers. , vol.6 , pp. 2071-2083
    • Muller, C.E.1
  • 19
    • 20344391910 scopus 로고    scopus 로고
    • Trends in solubility of polymorphs
    • M. Pudipeddi, and A.T. Serajuddin Trends in solubility of polymorphs J. Pharm. Sci. 94 2005 929 939
    • (2005) J. Pharm. Sci. , vol.94 , pp. 929-939
    • Pudipeddi, M.1    Serajuddin, A.T.2
  • 22
    • 0037467195 scopus 로고    scopus 로고
    • Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol
    • M. Sheu, S. Chen, L. Chen, and H. Ho Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol J. Controlled Release 88 2003 355 368
    • (2003) J. Controlled Release , vol.88 , pp. 355-368
    • Sheu, M.1    Chen, S.2    Chen, L.3    Ho, H.4
  • 23
    • 0030574681 scopus 로고    scopus 로고
    • The role of percutaneous penetration enhancers
    • R.B. Walker, and E.W. Smith The role of percutaneous penetration enhancers Adv. Drug Deliv. Rev. 18 1996 295 301
    • (1996) Adv. Drug Deliv. Rev. , vol.18 , pp. 295-301
    • Walker, R.B.1    Smith, E.W.2
  • 24
    • 0033427847 scopus 로고    scopus 로고
    • Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability
    • L. Yu, A. Bridges, J. Polli, A. Vickers, S. Long, A. Roy, R. Winnike, and M. Coffin Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability Pharm. Res. 16 1999 1812 1817
    • (1999) Pharm. Res. , vol.16 , pp. 1812-1817
    • Yu, L.1    Bridges, A.2    Polli, J.3    Vickers, A.4    Long, S.5    Roy, A.6    Winnike, R.7    Coffin, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.